Generation R Next - Optimaal Opgroeien
1 other identifier
interventional
1,750
1 country
1
Brief Summary
The aim of this randomized controlled trial is to improve birth outcomes and long-term outcomes in mother and child by optimizing lifestyle,nutrition and stress experience in the preconception period and early pregnancy in women and men The main research question that will be addressed is: Does an intervention focused on optimizing preconception and early pregnancy lifestyle, nutrition and stress improve the birth outcomes and long-term outcomes in mother and child? Participants will receive an individual lifestyle consultation at the start of the study. Depending on their study arm, participants will receive an additional lifestyle program focused on health during preconception and early pregnancy, coping with stress and adherence to a healthy(er) lifestyle. The given advices are based on national guidelines. Researchers will compare the intervention group and control group to see if (adherence to) this lifestyle program improve birth outcomes and long-term outcomes in mother and child.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2023
CompletedFirst Submitted
Initial submission to the registry
March 25, 2023
CompletedFirst Posted
Study publicly available on registry
May 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 8, 2030
September 4, 2024
August 1, 2024
3.3 years
March 25, 2023
August 30, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Preterm birth
Birth of the child before 37 weeks of pregnancy
Assessed at birth
Low birthweight/small-for-gestational-age
Birthweight below 10th percentile corrected for gestational age
Assessed at birth
High birthweight/large-for-gestational-age
Birthweight above 90th percentile corrected for gestational age
Assessed at birth
Low Apgar-score
Apgar-score assessed 5 minutes after birth, below 7 is considered as low with higher chance on worse outcome (scale: 0-10)
Assessed at birth
Birth weight
Birth weight measured continuously
Assessed at birth
Secondary Outcomes (19)
Adherence to lifestyle advice (mother)
During pregnancy and early childhood, until 12 months
Sleep/wake rhythm (mother)
During pregnancy and early childhood, until 12 months
Sleep/wake rhythm (mother)
During pregnancy and early childhood, until 12 months
Social support (mother)
During pregnancy and early childhood, until 12 months
Experience of stress (mother)
During pregnancy and early childhood, until 12 months
- +14 more secondary outcomes
Study Arms (2)
Standard care and additional lifestyle program
EXPERIMENTAL3 lifestyle group sessions (1 physical and 2 online) and additional online platform and individual consultation given at the research center by trained employees
Standard care
OTHERIndividual consultation given at the research center by trained employees
Interventions
Individual lifestyle consultation
Lifestyle program focusing on lifestyle advice, coping with stress and adherence to a healthy(er) lifestyle. This program consists of 3 group sessions and an online platform.
Eligibility Criteria
You may qualify if:
- Women and their parents:
- Planning a pregnancy or early pregnancy up to \< 12 weeks
- With the presence of at least one of the predetermined risk factors
- Residential address in the municipality of Rotterdam and expected residential address in the municipality of Rotterdam at the birth of their child
- Consent for participation
You may not qualify if:
- Women and their partners:
- Temporary or complete withdrawal from participation
- Gestational age \> 12+0 at study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- INDIGO Rijnmondcollaborator
- ZonMw: The Netherlands Organisation for Health Research and Developmentcollaborator
- Stichting Bevordering van Volkskrachtcollaborator
- Stichting Achmea Gezondheidszorcollaborator
- Bernard van Leer Foundationcollaborator
- Ministerie van Volksgezondheid, Welzijn en Sportcollaborator
Study Sites (1)
Erasmus MC
Rotterdam, 3015CN, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vincent Jaddoe, Prof.dr.
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
March 25, 2023
First Posted
May 23, 2023
Study Start
January 19, 2023
Primary Completion (Estimated)
May 8, 2026
Study Completion (Estimated)
November 8, 2030
Last Updated
September 4, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share